The current valuation score of Capricor Therapeutics Inc is 5.77, ranking 357 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.66, which is 0.00% below the recent high of -1.66 and -1189.42% above the recent low of -21.43.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.